Listed

Harrow, Inc.

HROWNasdaqCIK 1360214HealthcareFiscal year ends Dec 31

Latest reported revenue, Q2 FY2026$70.7mRevenue, Q2 FY2026, three months to 2026-06-30$70.7m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-08-10, accession 0001628280-26-055271.Report this figureThree months to Jun 30, 2026, from the 10-Q filed Aug 10, 2026.

Latest quarter: Q2 FY2026

Three months to Jun 30, 2026, against the same quarter a year earlier.

  • Revenue$70.7mRevenue, Q2 FY2026, three months to 2026-06-30$70.7m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-08-10, accession 0001628280-26-055271.Report this figure+10.9% on a year earlier
  • Gross margin71.3%Gross margin, Q2 FY2026, three months to 2026-06-30. gross profit / revenueGross profit: $50.4m. XBRL concept us-gaap:GrossProfit. 10-Q filed 2026-08-10, accession 0001628280-26-055271.Revenue: $70.7m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-08-10, accession 0001628280-26-055271.Report this figure−3.3 pts on a year earlier
  • Operating margin−15.6%Operating margin, Q2 FY2026, three months to 2026-06-30. operating income / revenueOperating income: −$11.0m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-08-10, accession 0001628280-26-055271.Revenue: $70.7m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-08-10, accession 0001628280-26-055271.Report this figure−33.5 pts on a year earlier
  • Net margin−24.4%Net margin, Q2 FY2026, three months to 2026-06-30. net income / revenueNet income: −$17.3m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-10, accession 0001628280-26-055271.Revenue: $70.7m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-08-10, accession 0001628280-26-055271.Report this figure−32.3 pts on a year earlier
  • Diluted EPS−$0.46Diluted EPS, Q2 FY2026, three months to 2026-06-30−$0.46 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-08-10, accession 0001628280-26-055271.Report this figureSign changed from a year earlier
  • Free cash flow−$10.2mFree cash flow, Q2 FY2026, three months to 2026-06-30. operating cash flow − capital expenditureOperating cash flow: −$9.8m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-08-10, accession 0001628280-26-055271. Derived: 6-month figure less the 3-month figure.Capital expenditure: $491.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-08-10, accession 0001628280-26-055271. Derived: 6-month figure less the 3-month figure.Report this figure−957.4% on a year earlier

Last eight quarters

Full statements
Revenue$70.7mGross margin 71.3%
Diluted EPS−$0.46, Q2 FY2026
Free cash flow−$10.2m, Q2 FY2026
Line itemUnitQ3 FY20242024-09-30Q4 FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30Q4 FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30
Revenue$m49.3Revenue, Q3 FY2024, three months to 2024-09-30$49.3m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-11-10, accession 0001493152-25-021562.Report this figure66.8Revenue, Q4 FY2024, three months to 2024-12-31$66.8m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-03-02, accession 0001493152-26-008562. Derived: 12-month figure less the 9-month figure.Report this figure47.8Revenue, Q1 FY2025, three months to 2025-03-31$47.8m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-05-11, accession 0001493152-26-022254.Report this figure63.7Revenue, Q2 FY2025, three months to 2025-06-30$63.7m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-08-10, accession 0001628280-26-055271.Report this figure71.6Revenue, Q3 FY2025, three months to 2025-09-30$71.6m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-11-10, accession 0001493152-25-021562.Report this figure89.1Revenue, Q4 FY2025, three months to 2025-12-31$89.1m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-03-02, accession 0001493152-26-008562. Derived: 12-month figure less the 9-month figure.Report this figure44.2Revenue, Q1 FY2026, three months to 2026-03-31$44.2m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-05-11, accession 0001493152-26-022254.Report this figure70.7Revenue, Q2 FY2026, three months to 2026-06-30$70.7m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-08-10, accession 0001628280-26-055271.Report this figure
Gross margin%75.6%Gross margin, Q3 FY2024, three months to 2024-09-30. gross profit / revenueGross profit: $37.2m. XBRL concept us-gaap:GrossProfit. 10-Q filed 2025-11-10, accession 0001493152-25-021562.Revenue: $49.3m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-11-10, accession 0001493152-25-021562.Report this figure78.8%Gross margin, Q4 FY2024, three months to 2024-12-31. gross profit / revenueGross profit: $52.7m. XBRL concept us-gaap:GrossProfit. 10-K filed 2026-03-02, accession 0001493152-26-008562. Derived: 12-month figure less the 9-month figure.Revenue: $66.8m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-03-02, accession 0001493152-26-008562. Derived: 12-month figure less the 9-month figure.Report this figure67.5%Gross margin, Q1 FY2025, three months to 2025-03-31. gross profit / revenueGross profit: $32.3m. XBRL concept us-gaap:GrossProfit. 10-Q filed 2026-05-11, accession 0001493152-26-022254.Revenue: $47.8m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-05-11, accession 0001493152-26-022254.Report this figure74.5%Gross margin, Q2 FY2025, three months to 2025-06-30. gross profit / revenueGross profit: $47.5m. XBRL concept us-gaap:GrossProfit. 10-Q filed 2026-08-10, accession 0001628280-26-055271.Revenue: $63.7m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-08-10, accession 0001628280-26-055271.Report this figure75.3%Gross margin, Q3 FY2025, three months to 2025-09-30. gross profit / revenueGross profit: $53.9m. XBRL concept us-gaap:GrossProfit. 10-Q filed 2025-11-10, accession 0001493152-25-021562.Revenue: $71.6m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-11-10, accession 0001493152-25-021562.Report this figure79.3%Gross margin, Q4 FY2025, three months to 2025-12-31. gross profit / revenueGross profit: $70.6m. XBRL concept us-gaap:GrossProfit. 10-K filed 2026-03-02, accession 0001493152-26-008562. Derived: 12-month figure less the 9-month figure.Revenue: $89.1m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-03-02, accession 0001493152-26-008562. Derived: 12-month figure less the 9-month figure.Report this figure61.2%Gross margin, Q1 FY2026, three months to 2026-03-31. gross profit / revenueGross profit: $27.0m. XBRL concept us-gaap:GrossProfit. 10-Q filed 2026-05-11, accession 0001493152-26-022254.Revenue: $44.2m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-05-11, accession 0001493152-26-022254.Report this figure71.3%Gross margin, Q2 FY2026, three months to 2026-06-30. gross profit / revenueGross profit: $50.4m. XBRL concept us-gaap:GrossProfit. 10-Q filed 2026-08-10, accession 0001628280-26-055271.Revenue: $70.7m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-08-10, accession 0001628280-26-055271.Report this figure
Operating margin%2.7%Operating margin, Q3 FY2024, three months to 2024-09-30. operating income / revenueOperating income: $1.3m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-11-10, accession 0001493152-25-021562.Revenue: $49.3m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-11-10, accession 0001493152-25-021562.Report this figure19.3%Operating margin, Q4 FY2024, three months to 2024-12-31. operating income / revenueOperating income: $12.9m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-03-02, accession 0001493152-26-008562. Derived: 12-month figure less the 9-month figure.Revenue: $66.8m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-03-02, accession 0001493152-26-008562. Derived: 12-month figure less the 9-month figure.Report this figure(23.5%)Operating margin, Q1 FY2025, three months to 2025-03-31. operating income / revenueOperating income: −$11.2m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-05-11, accession 0001493152-26-022254.Revenue: $47.8m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-05-11, accession 0001493152-26-022254.Report this figure17.9%Operating margin, Q2 FY2025, three months to 2025-06-30. operating income / revenueOperating income: $11.4m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-08-10, accession 0001628280-26-055271.Revenue: $63.7m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-08-10, accession 0001628280-26-055271.Report this figure20.6%Operating margin, Q3 FY2025, three months to 2025-09-30. operating income / revenueOperating income: $14.7m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-11-10, accession 0001493152-25-021562.Revenue: $71.6m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-11-10, accession 0001493152-25-021562.Report this figure17.5%Operating margin, Q4 FY2025, three months to 2025-12-31. operating income / revenueOperating income: $15.6m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-03-02, accession 0001493152-26-008562. Derived: 12-month figure less the 9-month figure.Revenue: $89.1m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-03-02, accession 0001493152-26-008562. Derived: 12-month figure less the 9-month figure.Report this figure(50.0%)Operating margin, Q1 FY2026, three months to 2026-03-31. operating income / revenueOperating income: −$22.1m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-05-11, accession 0001493152-26-022254.Revenue: $44.2m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-05-11, accession 0001493152-26-022254.Report this figure(15.6%)Operating margin, Q2 FY2026, three months to 2026-06-30. operating income / revenueOperating income: −$11.0m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-08-10, accession 0001628280-26-055271.Revenue: $70.7m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-08-10, accession 0001628280-26-055271.Report this figure
Net margin%(8.6%)Net margin, Q3 FY2024, three months to 2024-09-30. net income / revenueNet income: −$4.2m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-10, accession 0001493152-25-021562.Revenue: $49.3m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-11-10, accession 0001493152-25-021562.Report this figure10.1%Net margin, Q4 FY2024, three months to 2024-12-31. net income / revenueNet income: $6.8m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-03-02, accession 0001493152-26-008562. Derived: 12-month figure less the 9-month figure.Revenue: $66.8m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-03-02, accession 0001493152-26-008562. Derived: 12-month figure less the 9-month figure.Report this figure(37.2%)Net margin, Q1 FY2025, three months to 2025-03-31. net income / revenueNet income: −$17.8m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-05-11, accession 0001493152-26-022254.Revenue: $47.8m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-05-11, accession 0001493152-26-022254.Report this figure7.8%Net margin, Q2 FY2025, three months to 2025-06-30. net income / revenueNet income: $5.0m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-10, accession 0001628280-26-055271.Revenue: $63.7m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-08-10, accession 0001628280-26-055271.Report this figure1.4%Net margin, Q3 FY2025, three months to 2025-09-30. net income / revenueNet income: $1.0m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-10, accession 0001493152-25-021562.Revenue: $71.6m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-11-10, accession 0001493152-25-021562.Report this figure7.4%Net margin, Q4 FY2025, three months to 2025-12-31. net income / revenueNet income: $6.6m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-03-02, accession 0001493152-26-008562. Derived: 12-month figure less the 9-month figure.Revenue: $89.1m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-03-02, accession 0001493152-26-008562. Derived: 12-month figure less the 9-month figure.Report this figure(62.4%)Net margin, Q1 FY2026, three months to 2026-03-31. net income / revenueNet income: −$27.6m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-05-11, accession 0001493152-26-022254.Revenue: $44.2m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-05-11, accession 0001493152-26-022254.Report this figure(24.4%)Net margin, Q2 FY2026, three months to 2026-06-30. net income / revenueNet income: −$17.3m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-10, accession 0001628280-26-055271.Revenue: $70.7m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-08-10, accession 0001628280-26-055271.Report this figure
Diluted EPS$ per share(0.12)Diluted EPS, Q3 FY2024, three months to 2024-09-30−$0.12 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-11-10, accession 0001493152-25-021562.Report this figurenot reported(0.50)Diluted EPS, Q1 FY2025, three months to 2025-03-31−$0.50 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-05-11, accession 0001493152-26-022254.Report this figure0.13Diluted EPS, Q2 FY2025, three months to 2025-06-30$0.13 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-08-10, accession 0001628280-26-055271.Report this figure0.03Diluted EPS, Q3 FY2025, three months to 2025-09-30$0.03 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-11-10, accession 0001493152-25-021562.Report this figurenot reported(0.74)Diluted EPS, Q1 FY2026, three months to 2026-03-31−$0.74 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-05-11, accession 0001493152-26-022254.Report this figure(0.46)Diluted EPS, Q2 FY2026, three months to 2026-06-30−$0.46 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-08-10, accession 0001628280-26-055271.Report this figure
Free cash flow$m2.3Free cash flow, Q3 FY2024, three months to 2024-09-30. operating cash flow − capital expenditureOperating cash flow: $3.0m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-11-10, accession 0001493152-25-021562. Derived: 9-month figure less the 6-month figure.Capital expenditure: $604.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-11-10, accession 0001493152-25-021562. Derived: 9-month figure less the 6-month figure.Report this figure(18.3)Free cash flow, Q4 FY2024, three months to 2024-12-31. operating cash flow − capital expenditureOperating cash flow: −$17.8m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-03-02, accession 0001493152-26-008562. Derived: 12-month figure less the 9-month figure.Capital expenditure: $555.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-03-02, accession 0001493152-26-008562. Derived: 12-month figure less the 9-month figure.Report this figure19.5Free cash flow, Q1 FY2025, three months to 2025-03-31. operating cash flow − capital expenditureOperating cash flow: $19.7m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-05-11, accession 0001493152-26-022254.Capital expenditure: $170.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-05-11, accession 0001493152-26-022254.Report this figure(1.0)Free cash flow, Q2 FY2025, three months to 2025-06-30. operating cash flow − capital expenditureOperating cash flow: −$803.0k. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-08-10, accession 0001628280-26-055271. Derived: 6-month figure less the 3-month figure.Capital expenditure: $166.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-08-10, accession 0001628280-26-055271. Derived: 6-month figure less the 3-month figure.Report this figure16.4Free cash flow, Q3 FY2025, three months to 2025-09-30. operating cash flow − capital expenditureOperating cash flow: $16.6m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-11-10, accession 0001493152-25-021562. Derived: 9-month figure less the 6-month figure.Capital expenditure: $210.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-11-10, accession 0001493152-25-021562. Derived: 9-month figure less the 6-month figure.Report this figure8.1Free cash flow, Q4 FY2025, three months to 2025-12-31. operating cash flow − capital expenditureOperating cash flow: $8.4m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-03-02, accession 0001493152-26-008562. Derived: 12-month figure less the 9-month figure.Capital expenditure: $341.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-03-02, accession 0001493152-26-008562. Derived: 12-month figure less the 9-month figure.Report this figure(9.2)Free cash flow, Q1 FY2026, three months to 2026-03-31. operating cash flow − capital expenditureOperating cash flow: −$9.0m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-05-11, accession 0001493152-26-022254.Capital expenditure: $194.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-05-11, accession 0001493152-26-022254.Report this figure(10.2)Free cash flow, Q2 FY2026, three months to 2026-06-30. operating cash flow − capital expenditureOperating cash flow: −$9.8m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-08-10, accession 0001628280-26-055271. Derived: 6-month figure less the 3-month figure.Capital expenditure: $491.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-08-10, accession 0001628280-26-055271. Derived: 6-month figure less the 3-month figure.Report this figure

Focus or hover a figure to see its XBRL concept, period and filing; each links to that filing. A figure marked d is derived: a quarter computed from year-to-date figures, such as the fourth quarter as the fiscal year less the nine months before it. A ratio reads not reported when any input is missing.

Last five fiscal years

Revenue$272.3mGross margin 75.1%
Diluted EPS−$0.14, FY2025
Free cash flow$43.0m, FY2025
Line itemUnitFY20212021-12-31FY20222022-12-31FY20232023-12-31FY20242024-12-31FY20252025-12-31
Revenue$m72.5Revenue, FY2021, twelve months to 2021-12-31$72.5m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2023-03-23, accession 0001493152-23-008718.Report this figure88.6Revenue, FY2022, twelve months to 2022-12-31$88.6m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2024-03-19, accession 0001493152-24-010518.Report this figure130Revenue, FY2023, twelve months to 2023-12-31$130.2m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-03-02, accession 0001493152-26-008562.Report this figure200Revenue, FY2024, twelve months to 2024-12-31$199.6m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-03-02, accession 0001493152-26-008562.Report this figure272Revenue, FY2025, twelve months to 2025-12-31$272.3m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-03-02, accession 0001493152-26-008562.Report this figure
Gross margin%74.9%Gross margin, FY2021, twelve months to 2021-12-31. gross profit / revenueGross profit: $54.3m. XBRL concept us-gaap:GrossProfit. 10-K filed 2023-03-23, accession 0001493152-23-008718.Revenue: $72.5m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2023-03-23, accession 0001493152-23-008718.Report this figure71.3%Gross margin, FY2022, twelve months to 2022-12-31. gross profit / revenueGross profit: $63.2m. XBRL concept us-gaap:GrossProfit. 10-K filed 2024-03-19, accession 0001493152-24-010518.Revenue: $88.6m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2024-03-19, accession 0001493152-24-010518.Report this figure69.6%Gross margin, FY2023, twelve months to 2023-12-31. gross profit / revenueGross profit: $90.6m. XBRL concept us-gaap:GrossProfit. 10-K filed 2026-03-02, accession 0001493152-26-008562.Revenue: $130.2m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-03-02, accession 0001493152-26-008562.Report this figure75.3%Gross margin, FY2024, twelve months to 2024-12-31. gross profit / revenueGross profit: $150.4m. XBRL concept us-gaap:GrossProfit. 10-K filed 2026-03-02, accession 0001493152-26-008562.Revenue: $199.6m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-03-02, accession 0001493152-26-008562.Report this figure75.1%Gross margin, FY2025, twelve months to 2025-12-31. gross profit / revenueGross profit: $204.4m. XBRL concept us-gaap:GrossProfit. 10-K filed 2026-03-02, accession 0001493152-26-008562.Revenue: $272.3m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-03-02, accession 0001493152-26-008562.Report this figure
Operating margin%2.2%Operating margin, FY2021, twelve months to 2021-12-31. operating income / revenueOperating income: $1.6m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2023-03-23, accession 0001493152-23-008718.Revenue: $72.5m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2023-03-23, accession 0001493152-23-008718.Report this figure2.2%Operating margin, FY2022, twelve months to 2022-12-31. operating income / revenueOperating income: $1.9m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2024-03-19, accession 0001493152-24-010518.Revenue: $88.6m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2024-03-19, accession 0001493152-24-010518.Report this figure0.3%Operating margin, FY2023, twelve months to 2023-12-31. operating income / revenueOperating income: $431.0k. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-03-02, accession 0001493152-26-008562.Revenue: $130.2m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-03-02, accession 0001493152-26-008562.Report this figure4.4%Operating margin, FY2024, twelve months to 2024-12-31. operating income / revenueOperating income: $8.8m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-03-02, accession 0001493152-26-008562.Revenue: $199.6m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-03-02, accession 0001493152-26-008562.Report this figure11.2%Operating margin, FY2025, twelve months to 2025-12-31. operating income / revenueOperating income: $30.5m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-03-02, accession 0001493152-26-008562.Revenue: $272.3m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-03-02, accession 0001493152-26-008562.Report this figure
Net margin%(24.8%)Net margin, FY2021, twelve months to 2021-12-31. net income / revenueNet income: −$18.0m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2023-03-23, accession 0001493152-23-008718.Revenue: $72.5m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2023-03-23, accession 0001493152-23-008718.Report this figure(15.9%)Net margin, FY2022, twelve months to 2022-12-31. net income / revenueNet income: −$14.1m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2024-03-19, accession 0001493152-24-010518.Revenue: $88.6m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2024-03-19, accession 0001493152-24-010518.Report this figure(18.7%)Net margin, FY2023, twelve months to 2023-12-31. net income / revenueNet income: −$24.4m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-03-02, accession 0001493152-26-008562.Revenue: $130.2m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-03-02, accession 0001493152-26-008562.Report this figure(8.8%)Net margin, FY2024, twelve months to 2024-12-31. net income / revenueNet income: −$17.5m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-03-02, accession 0001493152-26-008562.Revenue: $199.6m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-03-02, accession 0001493152-26-008562.Report this figure(1.9%)Net margin, FY2025, twelve months to 2025-12-31. net income / revenueNet income: −$5.1m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-03-02, accession 0001493152-26-008562.Revenue: $272.3m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-03-02, accession 0001493152-26-008562.Report this figure
Diluted EPS$ per share(0.69)Diluted EPS, FY2021, twelve months to 2021-12-31−$0.69 per share. XBRL concept us-gaap:EarningsPerShareBasicAndDiluted. 10-K filed 2022-03-10, accession 0001493152-22-006525.Report this figure(0.51)Diluted EPS, FY2022, twelve months to 2022-12-31−$0.51 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-K filed 2024-03-19, accession 0001493152-24-010518.Report this figure(0.75)Diluted EPS, FY2023, twelve months to 2023-12-31−$0.75 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-K filed 2026-03-02, accession 0001493152-26-008562.Report this figure(0.49)Diluted EPS, FY2024, twelve months to 2024-12-31−$0.49 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-K filed 2026-03-02, accession 0001493152-26-008562.Report this figure(0.14)Diluted EPS, FY2025, twelve months to 2025-12-31−$0.14 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-K filed 2026-03-02, accession 0001493152-26-008562.Report this figure
Free cash flow$m3.3Free cash flow, FY2021, twelve months to 2021-12-31. operating cash flow − capital expenditureOperating cash flow: $5.1m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2023-03-23, accession 0001493152-23-008718.Capital expenditure: $1.8m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2023-03-23, accession 0001493152-23-008718.Report this figure(0.9)Free cash flow, FY2022, twelve months to 2022-12-31. operating cash flow − capital expenditureOperating cash flow: $1.7m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2024-03-19, accession 0001493152-24-010518.Capital expenditure: $2.6m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2024-03-19, accession 0001493152-24-010518.Report this figure2.4Free cash flow, FY2023, twelve months to 2023-12-31. operating cash flow − capital expenditureOperating cash flow: $3.8m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-03-02, accession 0001493152-26-008562.Capital expenditure: $1.5m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-03-02, accession 0001493152-26-008562.Report this figure(23.8)Free cash flow, FY2024, twelve months to 2024-12-31. operating cash flow − capital expenditureOperating cash flow: −$22.2m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-03-02, accession 0001493152-26-008562.Capital expenditure: $1.6m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-03-02, accession 0001493152-26-008562.Report this figure43.0Free cash flow, FY2025, twelve months to 2025-12-31. operating cash flow − capital expenditureOperating cash flow: $43.9m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-03-02, accession 0001493152-26-008562.Capital expenditure: $887.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-03-02, accession 0001493152-26-008562.Report this figure

Focus or hover a figure to see its XBRL concept, period and filing; each links to that filing. A figure marked d is derived: a quarter computed from year-to-date figures, such as the fourth quarter as the fiscal year less the nine months before it. A ratio reads not reported when any input is missing.

Insider purchases and sales

All insider transactions

The last 20 open-market transactions reported on Form 4 (codes P and S). The reported price is the price per share the insider stated on the form: filing data, not a market price.

No open-market purchases or sales by insiders are in coverage from Nov 2024 to Oct 2026.

No open-market purchases or sales by insiders are in coverage for this company.

Funds that report holding it

All funds

From each manager's latest Form 13F, largest reported value first. Reported value is as filed at the quarter end: filing data, not a price. A put or call is an option position, not shares held.

FundQuarter endedReported valueSharesPut or callChange on the quarter before
BlackRock, Inc.2026-06-30$116.4m2,740,117Added+187,358
Opaleye Management Inc.2026-06-30$101.9m2,400,000Reduced−432,230
Private Capital Management, LLC2026-06-30$67.9m1,598,770Added+36,770
VANGUARD CAPITAL MANAGEMENT LLC2026-06-30$60.2m1,417,212Added+14,156
Deep Track Capital, LP2026-06-30$41.2m969,000New+969,000
STATE STREET CORP2026-06-30$39.9m939,888Added+84,841
GEODE CAPITAL MANAGEMENT, LLC2026-06-30$38.5m905,560Added+53,526
BAMCO INC /NY/2026-06-30$34.4m809,350New+809,350
SUSQUEHANNA INTERNATIONAL GROUP, LLP2026-06-30$31.6m742,900CallAdded+37,900
DIMENSIONAL FUND ADVISORS LP2026-06-30$28.3m667,036Added+87,516

Recent filings

All 797 filings

Reports and events: 10-K, 10-Q, 8-K, proxy statements and ownership schedules.

FiledFormWhat it isAccession number
2026-10-0507:32 ET8-K1.01 Entry into a material agreement; 2.01 Completion of an acquisition or disposition; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001628280-26-064749
2026-09-0416:45 ET8-K5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits0001493152-26-041569
2026-08-1016:28 ET10-QQuarterly reportPeriod 2026-06-300001628280-26-055271
2026-08-1016:10 ET8-K2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001493152-26-036865
2026-08-0607:15 ET8-K1.01 Entry into a material agreement; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001493152-26-036256
2026-06-2207:30 ET8-K5.07 Shareholder vote results0001493152-26-029486
2026-06-0309:15 ET8-K7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001493152-26-026983
2026-05-1116:31 ET10-QQuarterly reportPeriod 2026-03-310001493152-26-022254
2026-05-1116:10 ET8-K2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001493152-26-022227
2026-04-2416:05 ETDEF 14AProxy statementPeriod 2025-12-310001493152-26-018912

Latest annual report

Form 10-K for the fiscal year ended Dec 31, 2025Filed Mar 2, 2026. Its page lists the documents and the extracted sections, such as Business and Risk factors.

Forecast league

Q3 FY2026, the quarter ended 2026-09-30, is open for forecasts until the first results filing for it is accepted by EDGAR. Results are due by [object Promise].Forecast this quarter

About the filer

CIK
1360214
Tickers
HROW
Exchange
Nasdaq
SIC code
2834 Pharmaceutical Preparations
Sector
Healthcare
Fiscal year ends
Dec 31
Incorporated in
DE
Filer category
Large accelerated filer
Former names
HARROW HEALTH, INC. (to 2023-09-20); Imprimis Pharmaceuticals, Inc. (to 2018-12-17); TRANSDEL PHARMACEUTICALS INC (to 2012-02-27); Bywater Resources, Inc (to 2007-09-12)

Source: SEC EDGAR, XBRL company facts, the filing index and Forms 4. Last ingested by Listed: Oct 27, 2026, 17:30 ET. Listed shows no prices and gives no investment advice.